Found "Public health policy": 1,044 results
The physical activity at work (PAW) study protocol: a cluster randomised trial of a multicomponent short-break intervention to reduce sitting time and increase physical activity among office workers in Thailand
Abstract
Background: High levels of sedentary behaviour (SB) are associated with non-communicable diseases. In 2016, the estimated total healthcare expenditure from physical activity (PA) in Thailand added up to $190 million in international dollars. The challenge to reduce SB and increase PA amo
Charging for the use of survey instruments on population health: the case of quality-adjusted life years
Abstract
A trend towards charging for access to research findings, tools and databases is becoming more prominent globally. But charging for the use of research tools and databases that are vital to research supporting national and international policy development might be unjustified. Financial
Filtering for the best policy: An economic evaluation of policy options for kidney replacement coverage in the Philippines
Abstract
Aim
Kidney failure patients in the Philippines have free choice on their kidney replacement therapy (KRT), with a majority choosing haemodialysis (HD) over peritoneal dialysis (PD) and transplantation despite the inadequate coverage of HD. Although national health insurance coverage is
A landscape analysis of health technology assessment capacity in the Association of South-East Asian Nations region
Abstract
Background
Progress towards achieving Universal Health Coverage and institutionalizing healthcare priority setting through health technology assessment (HTA) in the Association of South-East Asian Nations (ASEAN) region varies considerably across countries because of differences in heal
Challenges in ensuring global access to COVID-19 vaccines: production, affordability, allocation, and deployment
Summary
The COVID-19 pandemic is unlikely to end until there is global roll-out of vaccines that protect against severe disease and preferably drive herd immunity. Regulators in numerous countries have authorised or approved COVID-19 vaccines for human use, with more expected to be licensed in 20
Cost-effectiveness and budget impact analysis of facility-based screening and treatment of hepatitis C in Punjab state of India
ABSTRACT
Objective Despite treatment availability, chronic hepatitis C virus (HCV) public health burden is rising in India due to lack of timely diagnosis. Therefore, we aim to assess incremental cost per quality-adjusted life year (QALY) for one-time universal screening followed by treatment of
Co-production of evidence for policies in Thailand: from concept to action
KEY MESSAGES
• Thailand uses co-production of evidence, based on the concept of the “triangle that moves the mountain,” to support health policy making
• The annual national health assembly is a key platform for interactions between multiple stakeholders to adopt resolutions through consensus
•
An Introduction to the Main Types of Economic Evaluations Used for Informing Priority Setting and Resource Allocation in Healthcare: Key Features, Uses, and Limitations
Economic evidence is increasingly being used for informing health policies. However, the underlining principles of health economic analyses are not always fully understood by non-health economists, and inappropriate types of analyses, as well as inconsistent methodologies, may be being used for info
Using health technology assessment to set priority, inform target product profiles, and design clinical study for health innovation
Abstract
Early health technology assessment (early HTA) is a useful tool in guiding the innovation development process in medical technology development. However, the application of early HTA is sub-optimal amongst research and development (R&D) communities due to several challenges. In this pa
A protocol for a systematic literature review of economic evaluation studies of interventions to address antimicrobial resistance
Abstract
Background
Antimicrobial resistance (AMR) is accelerated by the widespread and often indiscriminate use of antimicrobials in humans, animals, and the environment. In 2015, the World Health Organization recognised AMR as one of the top ten global health threats, due to its potential to n
10 / Page